Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Dental Technologies Inc.
EIR
•Dental Technologies Inc.•March 12, 2019

Dental Technologies Inc. – FDA EIR, Mar 12, 2019

Record Details

Dental Technologies Inc., a manufacturer of non-sterile oral pharmaceutical products and medical devices, was subject to an FDA drug surveillance inspection from January 24 to March 12, 2019. Conducted under Compliance Program 7356.002, the inspection primarily focused on the company's Quality, Production, and Laboratory Controls Systems for drug manufacturing. The main violation, detailed in a one-point FDA-483, highlighted inadequate laboratory testing of drug products for objectionable microorganisms. The firm utilized an alternative microbiology method that did not align with current USP chapters <61> and <62>. Specific issues included deficient validation studies, such as incorrect microbial incubation times, failure to verify sample pH, and insufficient sample weights. Additionally, the company's routine microbiology test procedure lacked the USP-required duplicate plating. This observation marked a recurring issue for the company, having been cited in previous inspections and a 2011 Warning Letter. Management initiated immediate corrections during the inspection, successfully revising and implementing their change control procedure. They also began addressing ambiguities in their Out-Of-Specification procedure. Dental Technologies Inc. committed to submitting a written response to the FDA within 30 days outlining their detailed corrective and preventive actions. The company's registration for both drug and medical device manufacturing was verified.

Company
Dental Technologies Inc.
Inspection date
March 12, 2019
Product type
drugs
Office
Chicago District Office
People
  • Paula Erickson (company_representative)
  • Stephen A. Erickson (recipient)
  • Allison M. Bartuce (company_representative)
  • Nicholas P. DiOrio (investigator)
View Company Profile

ID · ea856e07-4693-4dd4-8352-01b37ff5c6a1

Violation Codes2
21 CFR 820.19821 CFR 211.165(b)

Full citation text and observation details available on the Dashboard.

Other documents for Dental Technologies Inc.
  • 483 - 2026-02-10February 10, 2026
  • WARNING_LETTER - 2021-01-20January 20, 2021
  • EIR - 2018-04-24April 24, 2018
  • EIR - 2017-06-29June 29, 2017
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dental Technologies Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.